Warning: Creating default object from empty value in /home/repoman/public_html/components/com_k2/views/itemlist/view.html.php on line 176
augmentin es

augmentin es

MDR-TB can be successfully treated during pregnancy by using a regimen including effective second-line anti-tuberculosis drugs. augmentin 0.

To compare the efficacy, safety and tolerability of a 3 day course of azithromycin with a 10 day course of co-amoxiclav in the treatment of children with acute lower respiratory tract infection (LRTI), 118 patients with community-acquired LRTI were included in a multicentre randomized double-blind, double-dummy study. The diagnosis of LRTI was based on the presence of respiratory signs and symptoms in combination with consolidation on a chest radiograph or clinical evidence of LRTI. Patients received oral azithromycin suspension (10 mg/kg/24 h) or placebo in one dose for 3 days and co-amoxiclav (45/11.25 mg/kg/24 h) or placebo in three doses for 10 days. Of 110 eligible patients, 56 and 54 patients, respectively, were treated with azithromycin or co-amoxiclav. The percentage of patients cured or clinically improved at days 10-13 (primary endpoint) was 91% for azithromycin and 87% for co-amoxiclav. This difference of 4% (90% confidence interval: -6%, +14%) was not statistically significant (P= 0.55). Significantly (P = 0.01) more related adverse events were found in the co-amoxiclav group. This was largely due to a higher percentage (43% versus 19%) of gastrointestinal complaints. A 3 day course of azithromycin (three doses) is as effective in the treatment of LRTI in children as a 10 day course of co-amoxiclav (30 doses). The azithromycin group had fewer adverse events. We conclude that azithromycin is an effective, safe and well-tolerated drug in the treatment of children with LRTI. An additional advantage is the easy administration and short duration of therapy. augmentin vaginal itching.

Authors have investigated the therapeutic problems in urinary infections caused by Streptococcus agalactiae in men and nonpregnant women. It is obvious from the literature that this problem has been considered mainly in pregnant women. On the basis of 86 patients (67 women and 19 men aged 14 to 81 years) it was established that the in vitro sensitivity of this Streptococcus was high (above 95%) to ampicillin, augmentin, cephalothin, lincomycin, chloramphenicol and erythromycin and 100% to rifampicin. For a successful treatment it is of great importance to establish the presence or lack of reservoirs of this infection (vagina, urethra, gastrointestinal tract). Mono- and combined antibiotic therapy was applied, as well as local treatment with vaginal lavages. Successful treatment is guaranteed by a thorough examination, identification of infection foci, including those outside the urinary system and choice of adequate individual approach to the patient. These variants are presented in detail. augmentin 750 dosage.

Call Us